Literature DB >> 7523679

Crystals of HIV-1 reverse transcriptase diffracting to 2.2 A resolution.

D K Stammers1, D O Somers, C K Ross, I Kirby, P H Ray, J E Wilson, M Norman, J S Ren, R M Esnouf, E F Garman.   

Abstract

Reverse transcriptase (RT) from the human immunodeficiency virus type 1 has been crystallized in four closely related forms, the best of which diffract X-rays to 2.2 A resolution. The RT was crystallized as a complex with a non-nucleoside inhibitor, either nevirapine or a nevirapine analogue. Crystals grew from 6% PEG 3400 buffered at pH 5. These were of space group P2(1)2(1)2(1) with unit cell parameters a = 147 A, b = 112 A, c = 79 A (form A), with one RT heterodimer in the asymmetric unit. Changes in unit cell parameters and degree of crystalline order were observed on soaking pregrown crystals in various solutions, giving three further sets of unit cells. These were a = 143 A, b = 112, A, c = 79 A (form B), a = 141 A, b = 111 A, c = 73 A (form C), a = 143 A, b = 117 A, c = 66.5 A (form D). The last two forms diffract X-rays to 2.2 A resolution. Structure determinations of these latter crystal forms of RT should give a detailed atomic model for this therapeutically important drug target.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523679     DOI: 10.1006/jmbi.1994.1604

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine.

Authors:  J Lennerstrand; D K Stammers; B A Larder
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

Authors:  J Ren; L E Bird; P P Chamberlain; G B Stewart-Jones; D I Stuart; D K Stammers
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-17       Impact factor: 11.205

3.  Biochemical studies on the mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to 1-(beta-D-dioxolane)thymine triphosphate.

Authors:  Johan Lennerstrand; Chung K Chu; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

4.  Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants.

Authors:  J Lennerstrand; K Hertogs; D K Stammers; B A Larder
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template.

Authors:  B Canard; R Sarfati; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

6.  Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor.

Authors:  R M Esnouf; J Ren; A L Hopkins; C K Ross; E Y Jones; D K Stammers; D I Stuart
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  Conformational analysis of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, based on quantum mechanical calculations.

Authors:  S Hannongbua; S Prasithichokekul; P Pungpo
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

8.  Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.

Authors:  P P Chamberlain; J Ren; C E Nichols; L Douglas; J Lennerstrand; B A Larder; D I Stuart; D K Stammers
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.

Authors:  J Ren; R M Esnouf; A L Hopkins; E Y Jones; I Kirby; J Keeling; C K Ross; B A Larder; D I Stuart; D K Stammers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptase.

Authors:  D V Nissley; P L Boyer; D J Garfinkel; S H Hughes; J N Strathern
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.